Emerging Role of Cetuximab in the Treatment of Colorectal Cancer

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 7, Iss. 2, 2012-05 ,pp. : 233-247

Bentham Science Publishers

Access to resources Recommend Favorite

Behavioral disorders secondary to profound hypomagnesemia in a patient given cetuximab for metastatic colorectal cancer hypomagnesemia due to cetuximab treatment

By Perrin Christophe   Fabre Cédric   Raoul Jean-Luc   Boucher Eveline  

Acta Oncologica, Vol. 45, Iss. 8, 2006-12 ,pp. : 1135-1136

Informa Healthcare

Access to resources Recommend Favorite

Impact of third-line treatment with irinotecan plus cetuximab on non-tumor standardized uptake values in patients with metastatic colorectal cancer

By        

Oncology Letters, Vol. 4, Iss. 1, 2012-01 ,pp. : 131-134

Spandidos Publications

Access to resources Recommend Favorite

How do we optimally use cetuximab in first-line treatment for metastatic colorectal cancer?

By Lindsay Colin R   Roxburgh Patricia   Graham Janet  

Future Oncology, Vol. 9, Iss. 6, 2013-06 ,pp. : 825-829

Future Medicine

Access to resources Recommend Favorite

Treatment related severe and fatal adverse events with cetuximab in colorectal cancer patients: a meta-analysis

By Zhang Di   Ye Junjie   Xu Tangpeng   Xiong Bin  

Journal of Chemotherapy, Vol. 25, Iss. 3, 2013-06 ,pp. : 170-175

Maney Publishing

Access to resources Recommend Favorite